The North America Cat Vaccine Market is projected to witness market growth of 8.7% CAGR during the forecast period (2024-2031).
The US market dominated the North America Cat Vaccine Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $637.8 million by 2031. The Canada market is experiencing a CAGR of 11% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2024 - 2031).
The market has been experiencing significant growth, driven by many factors ranging from increasing pet ownership to advancements in veterinary medicine. As the understanding of feline health continues to expand, the importance of vaccinations in safeguarding the well-being of cats has become increasingly evident. The increasing number of households adopting cats as pets is one of the most significant factors driving the growth of the market. People are increasingly recognizing the companionship and emotional benefits pets, particularly cats, can provide. Vaccinations are essential for preventing various infectious diseases affecting cats, ensuring they lead healthy and fulfilling lives.
Greater awareness about the importance of pet vaccinations has been a driving force in encouraging more pet owners to vaccinate their cats. This heightened awareness is primarily attributable to the initiatives of veterinary organizations and pet health campaigns, which underscore the critical role of vaccinations in the prevention of diseases. These initiatives have successfully educated pet owners about the benefits of vaccinations, leading to higher vaccination rates and healthier pets.
In Mexico, the demand for cat vaccines is increasing due to heightened public health concerns and growing pet ownership. The National Institute of Statistics and Geography (INEGI) reported that pet ownership, including cats, has increased in urban areas. Public health initiatives aimed at controlling rabies, such as the annual National Vaccination Week, have been crucial in promoting the importance of pet vaccinations. These campaigns, supported by the Ministry of Health, provide free or low-cost rabies vaccinations for pets, significantly boosting vaccination rates. Hence, rising pet ownership, increasing awareness of pet health, and a focus on preventative care are expected to continue driving the regional market forward.
The US market dominated the North America Cat Vaccine Market by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $637.8 million by 2031. The Canada market is experiencing a CAGR of 11% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2024 - 2031).
The market has been experiencing significant growth, driven by many factors ranging from increasing pet ownership to advancements in veterinary medicine. As the understanding of feline health continues to expand, the importance of vaccinations in safeguarding the well-being of cats has become increasingly evident. The increasing number of households adopting cats as pets is one of the most significant factors driving the growth of the market. People are increasingly recognizing the companionship and emotional benefits pets, particularly cats, can provide. Vaccinations are essential for preventing various infectious diseases affecting cats, ensuring they lead healthy and fulfilling lives.
Greater awareness about the importance of pet vaccinations has been a driving force in encouraging more pet owners to vaccinate their cats. This heightened awareness is primarily attributable to the initiatives of veterinary organizations and pet health campaigns, which underscore the critical role of vaccinations in the prevention of diseases. These initiatives have successfully educated pet owners about the benefits of vaccinations, leading to higher vaccination rates and healthier pets.
In Mexico, the demand for cat vaccines is increasing due to heightened public health concerns and growing pet ownership. The National Institute of Statistics and Geography (INEGI) reported that pet ownership, including cats, has increased in urban areas. Public health initiatives aimed at controlling rabies, such as the annual National Vaccination Week, have been crucial in promoting the importance of pet vaccinations. These campaigns, supported by the Ministry of Health, provide free or low-cost rabies vaccinations for pets, significantly boosting vaccination rates. Hence, rising pet ownership, increasing awareness of pet health, and a focus on preventative care are expected to continue driving the regional market forward.
List of Key Companies Profiled
- Zoetis, Inc.
- Elanco Animal Health, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Virbac
- Heska Corporation (Antech Diagnostics, Inc)
- Ceva Sante Animale
- Bioveta, a.s.
Market Report Segmentation
By Component- Combined Vaccines
- Mono Vaccines
- Injectables
- Intranasal
- Oral
- 1 Year
- 3 Year
- Others
- Feline Respiratory Diseases
- Feline Rabies
- Feline Panleukopenia (Feline Distemper)
- Feline Leukemia
- Others
- Modified/Attenuated Live
- Inactivated (Killed)
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. North America Cat Vaccine Market by Component
Chapter 6. North America Cat Vaccine Market by Route of Administration
Chapter 7. North America Cat Vaccine Market by Duration of Immunity
Chapter 8. North America Cat Vaccine Market by Disease Type
Chapter 9. North America Cat Vaccine Market by Type
Chapter 10. North America Cat Vaccine Market by Country
Chapter 11. Company Profiles
Companies Mentioned
- Zoetis, Inc.
- Elanco Animal Health, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Virbac
- Heska Corporation (Antech Diagnostics, Inc)
- Ceva Sante Animale
- Bioveta, a.s.
Methodology
LOADING...
